Craig Beasley — Chief Technology Officer at BlueRock Therapeutics

About Craig Beasley

Craig Beasley is Chief Technology Officer at BlueRock Therapeutics. Location: Greater Boston, United States.

Skills

GMP
Validation
FDA

Additional experience

VP Supply Chain, Cell Therapy
Bristol Myers Squibb
September 2016 – July 2021

Education

BS, Purdue University

Current role

Title: Chief Technology Officer
Company: BlueRock Therapeutics
Location: Greater Boston, United States
Started: August 2021

About BlueRock Therapeutics

BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, one for the treatment of Parkinson’s disease and one for the treatment of primary photoreceptor diseases, are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. For more information, visit www.bluerocktx.com.

Industry: Biotechnology Research
Company size: 201-500
Website: bluerocktx.com

About Craig Beasley

Skills

Additional experience

VP Supply Chain, Cell Therapy

Education